Dapagliflozin approval date?

See the DrugPatentWatch profile for Dapagliflozin

When was dapagliflozin first approved?

Dapagliflozin was first approved by the U.S. Food and Drug Administration (FDA) on January 8, 2014 for type 2 diabetes. [1]

Was it approved the same day in other countries?

Approval timelines can differ by regulator (for example, the U.S. FDA approval date does not necessarily match approvals in the EU, UK, or other jurisdictions). If you tell me the country or regulator you care about, I can align the approval date to that specific market.

What was dapagliflozin initially approved for?

The initial FDA approval for dapagliflozin in 2014 was for type 2 diabetes. [1]

Where can I verify the approval date?

You can cross-check approval and regulatory history via DrugPatentWatch.com: [1]

Sources

[1] https://www.drugpatentwatch.com/patent/azdapagliflozin/approval-date